Related Experiment Video
Updated: Apr 17, 2026

09:59
A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
Published on: September 16, 2017
14.7K
Temporal evolution of ischemic lesions in nonhuman primates: a diffusion and perfusion MRI study
Xiaodong Zhang1, Frank Tong2, Chun-Xia Li1
1Yerkes National Primate Research Center, Emory University, Atlanta, Georgia 30329, United States of America.
Plos One
|February 7, 2015
Summary
Stroke lesion growth in macaques follows a natural logarithmic pattern during the hyperacute phase. This pattern can help predict infarct volume changes in acute ischemic stroke.
Area of Science:
- Neuroscience
- Radiology
- Medical Imaging
Background:
- Stroke is a leading cause of death and disability worldwide.
- Understanding the spatiotemporal evolution of stroke lesions is crucial for developing effective treatments.
Purpose of the Study:
- To examine the evolution of ischemic stroke lesions in nonhuman primates using advanced MRI techniques.
- To characterize the spatiotemporal dynamics of infarct growth in the acute phase of stroke.
Main Methods:
- Permanent middle cerebral artery (MCA) occlusion was induced in adult rhesus monkeys.
- High-resolution diffusion-weighted imaging (DWI) and perfusion MRI were performed at multiple time points post-occlusion.
- Lesion volumes were quantified and validated with T2-weighted imaging (T2W) and H&E staining.
Main Results:
- Stroke infarcts exhibited a natural logarithmic growth pattern in the hyperacute phase (1-6 hours).
- Infarct volumes increased significantly from 6 to 96 hours post-occlusion.
- Diffusion-perfusion mismatch diminished by 48 hours, and logarithmic predictions correlated well with observed lesion volumes.
Conclusions:
- Infarct evolution follows a natural logarithmic pattern in the early stages of ischemic stroke.
- This logarithmic model can predict infarct volume growth in the acute phase.
- The nonhuman primate model and MRI protocols offer a robust platform for stroke research and therapeutic development.

